Clinical Trial

TubeClear System Evaluation in Pediatric Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Enteral access devices (EADs) provide necessary hydration, nutrition, and medications to numerous patients in hospitals across the United States. When patient's EAD becomes clogged it can delay administration of important nutrition and medications which can cause adverse effects such as malnutrition, and dehydration, especially in pediatric patients. Traditional methods of unclogging EADs can require the use of special enzymes or chemicals but these produce a variable rate of success. The TubeClear system has been developed to help alleviate the need for use of special enzymes or chemicals and to provide a quick, safe alternative for those with a clogged or sluggish EAD all while at the patient's bedside. This system prevents the need for subsequent exposure to radiation and contrast media for confirmation of EAD location after replacement.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-09
Trial Details
NCT Number NCT07570537
Lead Sponsor Children's Mercy Hospital Kansas City
Conditions Clogged Enteral Access Devices, Occluded Enteral Access Devices, Enteral Nutrition, Enteral Access Device, Tube Feeding, Gastric Feeding Tubes
Enrollment 20 participants
Start Date 2026-09-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-31